MicroTransponder Raises $2.7M

Dallas-based MicroTransponder, a developer of a medical device for the treatment of chronic pain, has raised $2.7M in funding, according to a recent regulatory filing by the firm. Source of the funding was not disclosed. According to the filing, the investment included both equity and warrants. MicroTransponder is developing wireless neurostimulation systems. MicroTransponder is headed by Will Rosellini. More information »